Ignite Creation Date:
2024-05-05 @ 4:42 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00294372
Status:
TERMINATED
Last Update Posted:
2013-11-14
First Post:
2006-02-20
Brief Title:
Phase II Study on the Antiviral Activity and Safety of BILR 355 BS in HIV-1 Infected NNRTI-treated Patients
Sponsor:
Organization:
Boehringer Ingelheim